FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

1811000001101: Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1512491000001115 Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1512501000001112 Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
16698501000001117 Molipaxin 150mg tablets (Aventis Pharma) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16698601000001118 Molipaxin 150mg tablets (Aventis Pharma) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37692301000001113 Molipaxin 150mg tablets (sanofi-aventis) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
65971901000001118 Molipaxin 150mg tablets (Sanofi) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
69342301000001111 Molipaxin 150mg tablets (Zentiva) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Is a Product containing precisely trazodone hydrochloride 150 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Has active ingredient Trazodone hydrochloride false Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Is a Molipaxin true Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient Trazodone hydrochloride true Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) 28 tablet 2 x 14 tablets Is pack of False Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Inferred relationship Existential restriction modifier
Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) 28 tablet 2 x 14 tablets Has AMP True Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start